Lazard announced that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals.
“Lazard’s deep expertise in healthcare and biopharma makes it an ideal platform to help clients tackle key strategic and financial challenges,” said Dr. Porges.
“We are thrilled to welcome Geoffrey to Lazard,” said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. “His deep understanding of the biopharmaceutical industry’s strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical and macroeconomic environment.”
Dr. Porges brings more than 30 years of experience in advisory, executive, and investment roles in the biopharmaceutical industry. Most recently, he served as EVP and Chief Financial Officer at Schrödinger, where he oversaw financial operations, investor relations, corporate communications, strategic planning and business development. Previously, he was the head of biopharma equity research at SVB Leerink and senior biotechnology equity research analyst Sanford C. Bernstein, consistently earning recognition as one of Wall Street’s top analysts. Earlier, Dr. Porges held senior roles at BTG PLC and Merck & Co.
“Lazard’s deep expertise in healthcare and biopharma makes it an ideal platform to help clients tackle key strategic and financial challenges,” said Dr. Porges. “I’m excited to join this world-class team and begin working with clients as they make critical decisions in a dynamic environment.”
Dr. Porges earned his medical degree from the University of Sydney and an MBA from Harvard Business School, where he was a Baker Scholar.
Health Technology Insights: Availity Names Bala Sekaran Chief Customer Officer
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
